Abstract
We investigate changes in gene expression of GluN1 subunit of N-Methyl-D-Aspartate (NMDA) receptor in the prefrontal cortex (PFC), hippocampus and striatum in a rat model of hepatic encephalopathy (HE). We used male Wistar rats in which HE was induced after a common bile duct ligation (BDL). The animals were divided into three sets, and each set included three groups of control, sham operated and BDL. In the first set of animals, blood samples collected for biochemical analysis on day 21 of BDL. In the second set, changes in nociception threshold was assessed on day 21 of BDL using a hotplate test. In the third set, whole brain extracted, and the PFC, the hippocampus and the striatum in each rat were immediately dissected. We used a semi-quantitative RT-PCR method for evaluating the GluN1 gene expression. The biochemical analyses showed that plasma levels of ammonia and bilirubin in BDL rats were significantly increased compared to the sham control group on day 21 of BDL (P < 0.01). Nociception threshold was also increased in rats with BDL compared to sham group (P < 0.001). The results revealed that the GluN1 gene expression at mRNA levels in BDL group was decreased by 19 % in the PFC (P < 0.05) but increased by 82 % in the hippocampus (P < 0.01) compared to the sham control group; however, no significant change was observed in the striatum. It can be concluded that HE affects the GluN1 gene expression in rat brain with a site-specific pattern, and the PFC and hippocampus are more sensitive areas than striatum.
Similar content being viewed by others
References
Adler RD, Wannagat FJ, Ockner RK (1977) Bile secretion in selective biliary obstruction. Adaptation of taurocholate transport maximum to increased secretory load in the rat. Gastroenterology 73:129–136
Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh J (2015) Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain. Neuroscience 284:78–86
Alemi F et al (2013) The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 123:1513–1530
Benedetti A et al (1997) Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 26:9–21
Bergasa NV, Sabol SL, Young WS 3rd, Kleiner DE, Jones EA (1995) Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 268:G346–G354
Butterworth RF (2008) Pathophysiology of hepatic encephalopathy: the concept of synergism. Hepatol Res 38(Suppl 1):S116–S121
Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29:783–788
Cauli O, Mansouri MT, Agusti A, Felipo V (2009a) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136:1359–1367, e1351–1352
Cauli O et al (2009b) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24:69–80
Cauli O et al (2014) Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. Neuromol Med 16:360–375
Chiu K, Lau WM, Lau HT, So KF, Chang RC (2007) Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp 7:269
Da Silva LF, Walder RY, Davidson BL, Wilson SP, Sluka KA (2010) Changes in expression of NMDA-NR1 receptor subunits in the rostral ventromedial medulla modulate pain behaviors. Pain 151:155–161
Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 14:851–858
Garcia-Ayllon MS et al (2008) Brain cholinergic impairment in liver failure. Brain 131:2946–2956
Glasgow NG, Siegler Retchless B, Johnson JW (2015) Molecular bases of NMDA receptor subtype-dependent properties. J Physiol 593:83–95
Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Allahtavakoli M, Ghaseminejad M (2007) Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. Eur J Pharmacol 554:123–127
Huang LT, Hsieh CS, Chou MH, Chuang JH, Liou CW, Tiao MM, Lai MC (2004) Obstructive jaundice in rats: cause of spatial memory deficits with recovery after biliary decompression. World J Surg 28:283–287
Incontro S, Asensio CS, Edwards RH, Nicoll RA (2014) Efficient, complete deletion of synaptic proteins using CRISPR. Neuron 83:1051–1057
Jayanthi S et al (2014) Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms. Biol Psychiatry 76:47–56
Keil GJ 2nd, Delander GE (1995) Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J Pharmacol Exp Ther 274:1387–1392
Llansola M et al (2013) Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations. Metab Brain Dis 28:151–154
Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, Butterworth RF (2004) Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 40:742–748
Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51:528–534
Maillette de Buy Wenniger L, Beuers U (2010) Bile salts and cholestasis. Dig Liver Dis 42:409–418
Marone M, Mozzetti S, De Ritis D, Pierelli L, Scambia G (2001) Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 3:19–25
National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the care and use of laboratory animals. 8th edition. National Academies Press (US), Washington (DC)
Nicoll J, Axiotis CA, Bergasa NV (2005) The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 65:1099–1105
Olde Damink SW, Jalan R, Dejong CH (2009) Interorgan ammonia trafficking in liver disease. Metab Brain Dis 24:169–181
Ossipov MH, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J (1990) Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 73:1227–1235
Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33:1351–1365
Paoletti P, Neyton J (2007) NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 7:39–47
Piovesan EJ et al (2008) Influence of NMDA and non-NMDA antagonists on acute and inflammatory pain in the trigeminal territory: a placebo control study. Arq Neuropsiquiatr 66:837–843
Priya A, Johar K, Wong-Riley MT (2013) Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B. Biochim Biophys Acta 1833:2745–2756
Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139:675–684
Rodriguez-Garay EA (2003) Cholestasis: human disease and experimental animal models. Ann Hepatol 2:150–158
Rodriguez-Munoz M, Sanchez-Blazquez P, Vicente-Sanchez A, Berrocoso E, Garzon J (2012) The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37:338–349
Rousseaux C (2008) A review of glutamate receptors I: current understanding of their biology. J Toxicol Pathol 21:25–21
Sanz-Clemente A, Nicoll RA, Roche KW (2013) Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist Rev J Neurobiol Neurol Psychiatry 19:62–75
Tian Q et al (2004) Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics MCP 3:960–969
Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA (1997) Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25:820–827
Wen S, Schroeter A, Klocker N (2013) Synaptic plasticity in hepatic encephalopathy—a molecular perspective. Arch Biochem Biophys 536:183–188
Wright G et al. (2010) Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol 53:91–97
Zhou HY, Chen SR, Pan HL (2011) Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol 4:379–388
Funding
This study was not funded by any grant and/or financial support.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
“All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmadi, S., Poureidi, M. & Rostamzadeh, J. Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain. Metab Brain Dis 30, 1035–1041 (2015). https://doi.org/10.1007/s11011-015-9669-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-015-9669-x